- Research works
- 3 fractional, all time
- Citations
- 156 61.7 per fractional work
- Top-10% rate
- 100.0% record average 16.5%
- Open access
- 28% world 28%
Not ranked overall: SLA Pharma (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does SLA Pharma (United Kingdom) publish most on?
By volume in 2022–2025: Poisoning and overdose treatments, Opioid Use Disorder Treatment and Neuroscience of respiration and sleep.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Poisoning and overdose treatments Emergency Medicine 0 works
- 2 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 0 works
- 3 Neuroscience of respiration and sleep Endocrine and Autonomic Systems 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has SLA Pharma (United Kingdom)'s research output changed?
Other research institutions in Watford
- Building Research Establishment
- NHS Blood and Transplant
- Watford General Hospital
- West Hertfordshire Hospitals NHS Trust
- Action for Children
- Kodak (United Kingdom)
- West Herts College
- Vinci (United Kingdom)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.